Age 0 3 0 3 B-age
: 3 4 3 4 O
17 5 7 5 7 B-upper_bound
years 8 13 8 13 I-upper_bound
or 14 16 14 16 O
less 17 21 17 21 O
at 22 24 22 24 O
time 25 29 25 29 O
of 30 32 30 32 O
enrollment 33 43 33 43 O

Breast 0 6 44 50 O
- 6 7 50 51 O
feeding 7 14 51 58 O
females 15 22 59 66 B-gender

Children 0 8 67 75 O
with 9 13 76 80 O
severe 14 20 81 87 B-chronic_disease
renal 21 26 88 93 I-chronic_disease
impairment 27 37 94 104 I-chronic_disease
will 38 42 105 109 O
not 43 46 110 113 O
be 47 49 114 116 O
enrolled 50 58 117 125 O

Patients 0 8 126 134 O
who 9 12 135 138 O
are 13 16 139 142 O
older 17 22 143 148 O
than 23 27 149 153 O
17 28 30 154 156 B-lower_bound
years 31 36 157 162 I-lower_bound
will 37 41 163 167 O
not 42 45 168 171 O
be 46 48 172 174 O
enrolled 49 57 175 183 O

Post 0 4 184 188 O
- 4 5 188 189 O
pubertal 5 13 189 197 O
females 14 21 198 205 B-gender
who 22 25 206 209 O
are 26 29 210 213 O
pregnant 30 38 214 222 B-pregnancy

Subjects 0 8 223 231 O
must 9 13 232 236 O
have 14 18 237 241 O
a 19 20 242 243 O
documented 21 31 244 254 O
infantile 32 41 255 264 B-chronic_disease
or 42 44 265 267 I-chronic_disease
juvenile 45 53 268 276 I-chronic_disease
gangliosidosis 54 68 277 291 I-chronic_disease
disease 69 76 292 299 I-chronic_disease

Subjects 0 8 300 308 O
who 9 12 309 312 O
have 13 17 313 317 O
an 18 20 318 320 O
allergy 21 28 321 328 O
to 29 31 329 331 O
miglustat 32 41 332 341 B-allergy_name
or 42 44 342 344 O
any 45 48 345 348 O
of 49 51 349 351 O
the 52 55 352 355 O
components 56 66 356 366 O
within 67 73 367 373 O
the 74 77 374 377 O
drug 78 82 378 382 O
product 83 90 383 390 O

who 0 3 391 394 O
are 4 7 395 398 O
unwilling 8 17 399 408 O
to 18 20 409 411 O
use 21 24 412 415 O
highly 25 31 416 422 O
- 31 32 422 423 O
effective 32 41 423 432 O
methods 42 49 433 440 O
to 50 52 441 443 O
prevent 53 60 444 451 O
pregnancy 61 70 452 461 B-pregnancy

